Sterne Agee Upgrades Imperva (IMPV) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- Harry and Meghan surprised by King Charles' letter on their status
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Deutsche Bank Downgrades Imperva (IMPV) to Hold
April 10, 2014 8:55 AM EDTDeutsche Bank downgraded Imperva (NYSE: IMPV) from Buy to Hold with a price target of $40.00 (from $60.00).
Analyst Nandan Amladi said, "IMPV negatively preannounced its Q114 numbers, guiding down its Rev and EPS. It now expects Rev/ EPS of $31.0m - $31.5m / ($0.40) ($0.44) vs prior guide of $36.0 - $37.0m/... More
Oppenheimer Downgrades Imperva (IMPV) to Perform
April 10, 2014 6:25 AM EDTOppenheimer downgraded Imperva (NYSE: IMPV) from Outperform to Perform and removed their $65 price target following the company's Q1 warning.
Analyst Shaul Eyal siad, "Our downgrade is driven by: 1.) negative 1Q pre-announcement driven mainly by US weakness; 2.) increased competition for >$100K deals; 3.) our... More
FireEye (FEYE), Fortiet (FTNT) Dip on Imperva (IMPV) Warning
April 9, 2014 4:28 PM EDTFireEye, Inc. (NASDAQ: FEYE) and Fortinet (Nasdaq: FTNT) are lower following preliminary Q1 results from peer Imperva, Inc. (NYSE: IMPV).
After markets closed, Imperva said that it expected Q1 reveneu of $31 to $31.5... More
Imperva, Inc. (IMPV) Warns for Q1
April 9, 2014 4:08 PM EDTImperva, Inc. (NYSE: IMPV) expects to report total revenue for the first quarter of 2014 in the range of $31.0 million to $31.5 million compared to the companys prior guidance of total revenue in the range of $36.0 million to $37.0 million. The consensus is $36.7 million.
Imperva also expects to report non-GAAP operating loss in the first quarter of 2014 in the range of $(9.5) million to $(10.5) million, and expects to report non-GAAP net loss per share attributable to Imperva stockholders in the range of $(0.40) to $(0.44) using approximately 25.2 million... More
